Upregulation of IGF1R and/or INSR constitutes a common paradigm mediating tumor resistance [11,12] in different cancer types and is associated with poor prognosis in prostate cancer, squamous cell lung cancer, and prostate cancer [13,14,15]. Here, IGF1R is linked to neoplasm.